Development and Evaluation of a Cost-Effective, Carbon-Based, Extended-Release Febuxostat Tablet

Development and Evaluation of a Cost-Effective, Carbon-Based, Extended-Release Febuxostat Tablet

This study outlines the development of a cost-effective, extended-release febuxostat (FEB) tablet using activated charcoal as an adsorbent to enhance drug release. FEB, a BCS Class II drug, presents formulation challenges due to low solubility and high lipophilicity. We evaluated eight formulations...

Full description

Saved in:
Bibliographic Details
Main Authors: Israa Hamid Al-Ani, Mohammad Hailat, Dina J. Mohammed, Sina Mahmoud Matalqah, Alaa Azeez Abu Dayah, Bashar J. M. Majeed, Riad Awad, Lorena Filip, Wael Abu Dayyih
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Molecules
Subjects:
FEB
extended release
bioavailability
charcoal
tablet
Online Access:https://www.mdpi.com/1420-3049/29/19/4629
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1420-3049/29/19/4629

Similar Items